Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.

NCT01427010 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01427010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01427010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
August 31, 2015
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

re-irradiation in recurrent and second primary head and neck cancer